These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9059974)

  • 1. Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G.
    Bellati G; Colloredo G; Roffi L; D'Aquino M; Bonino F; Idéo G
    J Hepatol; 1997 Feb; 26(2):449-50. PubMed ID: 9059974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon treatment for chronic hepatitis C--assessment of 3 regimens in patients received more than 500 MU interferon treatment and their effect predictive factors for interferon treatment using multivariate analysis with the logistic regression model].
    Terada M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1007-11. PubMed ID: 7563657
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-interferon antibodies during interferon therapy for chronic hepatitis C.
    Bonetti P; Chemello L; Alberti A
    J Hepatol; 1994 Jul; 21(1):135. PubMed ID: 7963414
    [No Abstract]   [Full Text] [Related]  

  • 5. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.
    Bjøro K; Krarup H; Bell H; Christophersen P; Evensen S; Frøland SS; Laursen A; B vd Lippe B; Maeland A; Ranek L
    Scand J Gastroenterol; 1995 Nov; 30(11):1119-24. PubMed ID: 8578174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term/intermittent treatment of chronic hepatitis C with recombinant interferon alfa-2b].
    Hakozaki Y; Fujioka T; Katou M; Kondo T; Oba K; Nakagawa K; Shirahama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1001-6. PubMed ID: 7563656
    [No Abstract]   [Full Text] [Related]  

  • 7. Retreatment of chronic hepatitis C with interferon-alpha.
    Marriott E; Quiroga JA; Carreño V
    J Infect Dis; 1992 Nov; 166(5):1200-1. PubMed ID: 1402039
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete response to twice-a-day interferon-beta with standard interferon-alpha therapy in acute hepatitis C after a needle-stick.
    Oketani M; Higashi T; Yamasaki N; Shinmyozu K; Osame M; Arima T
    J Clin Gastroenterol; 1999 Jan; 28(1):49-51. PubMed ID: 9916668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment algorithms for hepatitis B and C.
    Schiff ER
    Gut; 1993; 34(2 Suppl):S148-9. PubMed ID: 8314487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 11. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
    Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
    [No Abstract]   [Full Text] [Related]  

  • 12. Experts recommend longer treatment for hepatitis C virus.
    Roper CR; Ford D
    AORN J; 1995 Sep; 62(3):358. PubMed ID: 8534054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two cases of acute exacerbation of chronic hepatitis C improved after the administration of an immunosuppressive drug and interferon].
    Ikeda H; Nishina K; Asatani Y; Yumoto E; Okano N; Seno H; Yamano T; Kiyono T; Konishi A; Inoue T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Aug; 92(8):1200-5. PubMed ID: 7563929
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ; Azzouz M; Van Thiel DH
    Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Containing hepatitis C.
    Maddrey WC
    Hosp Pract (1995); 1997 Mar; 32(3):107-9, 113-4 passim; discussion 128. PubMed ID: 9078976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
    Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
    J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.
    Bekkering FC; Brouwer JT; Leroux-Roels G; Van Vlierberghe H; Elewaut A; Schalm SW
    J Hepatol; 1998 Jun; 28(6):960-4. PubMed ID: 9672170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid growth of hepatocellular carcinoma after or during interferon treatment of chronic hepatitis C: report of three cases.
    Onitsuka A; Yamada N; Yasuda H; Miyata T; Kachi T
    Surg Today; 1996; 26(2):126-30. PubMed ID: 8919284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Despite improved healing chances with pegylated interferon, hepatitis C is frequently not optimally treated].
    MMW Fortschr Med; 2002 Dec; 144(49):61. PubMed ID: 12577749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.